Obeticholic Acid Treatment in Patients With Bile Acid Diarrhoea: an Open-label, Pilot Study of Mechanisms, Safety and Symptom Response.

Trial Profile

Obeticholic Acid Treatment in Patients With Bile Acid Diarrhoea: an Open-label, Pilot Study of Mechanisms, Safety and Symptom Response.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2014

At a glance

  • Drugs Obeticholic acid (Primary)
  • Indications Crohn's disease; Diarrhoea; Primary bile acid malabsorption
  • Focus Pharmacodynamics
  • Acronyms OBADIAH; OBADIAH1
  • Most Recent Events

    • 06 May 2014 The new OBADIAH trial results were presented at Digestive Disease Week 2014 in Chicago, according to Intercept Pharmaceuticals media release.
    • 28 Jan 2014 New trial record
    • 09 Jan 2014 Initial results were published in the Intercept Pharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top